financetom
Business
financetom
/
Business
/
Unicredit chief hopes for clarity on Commerzbank plans by end 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Unicredit chief hopes for clarity on Commerzbank plans by end 2025
Jan 22, 2025 6:32 AM

BERLIN (Reuters) - UniCredit chief Andrea Orcel wants to discuss a planned takeover of Commerzbank with the new German government and hopes for some clarity at the latest by the end of the year, he told German paper FAZ.

Germans will elect a new government on Feb. 23 and polls suggest that conservative chancellor candidate Friedrich Merz could succeed Chancellor Olaf Scholz, a Social Democrat, who opposes the deal.

"Without the support of such an important institution as the German government it will be difficult," Orcel was quoted as saying in an interview. "I hope for the summer. Overall we should know where we stand by the end of the year at the latest."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TikTok to label AI-generated content from OpenAI and elsewhere
TikTok to label AI-generated content from OpenAI and elsewhere
May 9, 2024
May 9 (Reuters) - TikTok plans to start labelling images and video uploaded to its video-sharing service that have been generated using artificial intelligence, it said on Thursday, using a digital watermark known as Content Credentials. Researchers have expressed concern that AI-generated content could be used to interfere with U.S. elections this fall, and TikTok was already among a group...
Royalty Pharma to Acquire Frexalimab Royalties, Milestones for $525 Million in Cash
Royalty Pharma to Acquire Frexalimab Royalties, Milestones for $525 Million in Cash
May 9, 2024
10:44 AM EDT, 05/09/2024 (MT Newswires) -- Royalty Pharma ( RPRX ) said Thursday it will acquire the royalties and milestones on frexalimab owned by ImmuNext for about $525 million in cash. Frexalimab, in development by Sanofi ( SNY ) , is being evaluated in three phase 3 clinical studies as a treatment for multiple sclerosis, a disease that affects...
Update: Market Chatter: Alphabet's Talks to Acquire HubSpot Advance
Update: Market Chatter: Alphabet's Talks to Acquire HubSpot Advance
May 9, 2024
10:41 AM EDT, 05/09/2024 (MT Newswires) -- (Updates with additional information) Alphabet (GOOG, GOOGL) is in advanced discussions to acquire HubSpot ( HUBS ) , negotiating terms of a potential deal, Bloomberg reported Thursday, citing people familiar with the matter. The companies are still in talks, with no final agreement reached yet, and there's no assurance that a deal will...
Merck Says Health Canada Approve Keytruda Combination in Biliary Tract Carcinoma
Merck Says Health Canada Approve Keytruda Combination in Biliary Tract Carcinoma
May 9, 2024
10:43 AM EDT, 05/09/2024 (MT Newswires) -- Merck ( MRK ) said Thursday that Health Canada has approved Keytruda plus gemcitabine-based chemotherapy for treating adults with locally advanced unresectable or metastatic biliary tract carcinoma, or BTC. BTC is a group of aggressive cancers in the gallbladder and bile ducts and the second most common type of primary liver cancer, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved